The future of cellular therapy for the treatment of renal cell carcinoma

Nada Chaoul,Eleonora Lauricella,Andrea Giglio,Gabriella D’Angelo,Carlo Ganini,Mauro Cives,Camillo Porta
DOI: https://doi.org/10.1080/14712598.2024.2418321
2024-11-06
Expert Opinion on Biological Therapy
Abstract:Introduction Systemic treatment options for renal cell carcinoma (RCC) have expanded considerably in recent years, and both tyrosine kinase inhibitors and immune checkpoint inhibitors, alone or in combination, have entered the clinical arena. Adoptive cell immunotherapies have recently revolutionized the treatment of cancer and hold the promise to further advance the treatment of RCC.
medicine, research & experimental,biotechnology & applied microbiology
What problem does this paper attempt to address?